Mainz Biomed B.V. MYNZ
3.59 USD 0.00 (+0.00%)
May 22, 2026, 12:35 PM EDT
3.38 Day range 3.72
52-week range unavailable
- YTD
- +220.54%
- 1 year
- +41.34%
Financial health
Altman Z-Score
-4.37 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.4×
FY 2019 5y median -28.6× FY 2025
P/S 12.5×
FY 2019 5y median 842× FY 2025
P/B 10.5×
FY 2019 5y median 232× FY 2025
P/FCF -0.6×
FY 2019 5y median -31.6× FY 2025
EV/EBITDA -0.7×
FY 2019 5y median -29.9× FY 2025
EV/Sales 15.6×
FY 2019 5y median 842× FY 2025
FCF Yield -163.5%
FY 2019 5y median -3.2% FY 2025
Profitability
Gross Margin -42.1%
FY 2019 5y median 34.4% FY 2025
Operating Margin -2513.4%
FY 2019 5y median -2513.4% FY 2025
Net Margin -3018.3%
FY 2019 5y median -2936.5% FY 2025
ROE -2526.6%
FY 2019 5y median -358.1% FY 2025
ROIC -420.1%
FY 2019 5y median -192.9% FY 2025
ROA -304.3%
FY 2019 5y median -163.5% FY 2025
Growth (YoY)
Revenue -39.9%
FY 2019 FY 2025
Operating Income 27.8%
FY 2019 FY 2025
EPS (diluted) 87.9%
FY 2019 FY 2025
Free Cash Flow 36.7%
FY 2019 FY 2025
Financial Health
Current Ratio 0.5×
FY 2019 5y median 1.3× FY 2025
Quick Ratio 0.4×
FY 2019 5y median 1.3× FY 2025
Debt / Equity 4.0×
FY 2019 5y median 0.5× FY 2025
Net Debt / EBITDA -0.1×
FY 2019 5y median 0.2× FY 2025
Interest Coverage 36.1×
FY 2019 5y median -28.7× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
